Dwight Dishmon, MD
Interventional Cardiology · Memphis, TNNPI 1316904048
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 47 manufacturers reported payments, led by Avinger Inc. at 33.4% of the total. Reporting peaked in 2021 at $45,989 and has fallen 85.9% since, to $6,495 in 2025. Among interventional cardiology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 928 payments — averaging $143.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avinger Inc.$44K
- Johnson & Johnson$16K
- Bard Peripheral Vascular, Inc.$13K
- Medtronic$10K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$10K
- Alnylam Pharmaceuticals Inc.$10K
- plus $29K from 41 others
Across 4 payments — averaging $1587.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$6K
What the payments were for
- Consulting fees$10,2958%
- Speaking & faculty fees$64,08548%
- Travel & lodging$14,68411%
- Food & beverage$43,70933%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PANTHERIS$38,853
- XARELTO$15,150
- LifeVest$9,000
- LUTONIX$8,149
- Indigo System$4,651
- ONPATTRO$3,924
- HawkOne$3,256
- Resolute$2,134
- OptoWire$1,639
- RotarexS 6 F x 135 cm$1,361
- Auryon Laser System 100-120 Vac$1,043
- Diamondback Peripheral$766
- Penumbra System$679
- Omnilink Elite vascular stent system$592
- EKOSONIC$545
- Vascular Lithotripsy$519
- TurboHawk$504
- ENDURANT IIS$474
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$452
- Cios Alpha$413
How this compares
$132,789 in reported general payments places this provider in the 90th percentile of 207 interventional cardiology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 30 | $31,604 |
| XareltoRivaroxaban | 15 | $11,417 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 12 | $2,668 |
| ClopidogrelClopidogrel Bisulfate | 119 | $1,576 |
| Nifedipine ErNifedipine | 23 | $420 |
| Metoprolol Succinate | 16 | $233 |
| Carvedilol | 28 | $203 |
| Amlodipine Besylate | 15 | $128 |
| Metoprolol Tartrate | 11 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $224 | $31,60430 claims |
| Johnson & JohnsonXarelto | $15,783 | $11,41715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 207 interventional cardiology providers in Tennessee.
Other interventional cardiology in Memphis
- Joseph WeinsteinMemphis$218K
- Claro DiazMemphis$109K
- Benjamin WallerMemphis$52K
- Mohamed MorsyMemphis$20K
- Stevan HimmelsteinMemphis$15K
- Jimmy KerriganNashville$644K
- Kashish GoelNashville$558K
- Brian JeffersonNashville$547K
- Malcolm FosterKnoxville$413K
- Mehul PatelGermantown$382K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.